Tesco
Technology Quarterly: Targeting Tumours
Article

Technology Quarterly: Targeting Tumours

In rich countries half of cancers are now survivable. And better understanding means that more cures are coming, says Natasha Loder.

The Economist
The Economist, 2017
Read the article

Read or listen offline

автоматическое преобразование текста в аудио
  • 0.5×
  • 0.75×
  • 1×
  • 1.25×
  • 1.5×
  • 1.75×
1×
автоматическое преобразование текста в аудио

Editorial Rating

8

Qualities

  • Innovative
  • Scientific
  • Hot Topic

Recommendation

The Economist’s health care correspondent, Natasha Loder, delves into the status and future of cancer treatment in this incredibly thorough report. She focuses on the science, biotechnology and economics behind treating this deadly disease. While the subject matter is technical and complex, the piece is a fascinating look at one patient’s story, set against the background of extensive research and development of new strategies in the cancer world. getAbstract recommends this article to anyone in biotechnology, as well as physicians, scientists, and those whose lives have been touched by cancer.

Take-Aways

  • New technologies that detect cancer earlier after its onset – based on blood or breath tests – could improve outcomes. But, to be effective, these methods must be specific and sensitive.
  • Treatments – including drugs, surgical techniques and radiotherapy – continue to improve, but cancer can evolve to render them ineffective.
  • Immunotherapy methods and drugs, those which stimulate the body’s own defenses against cancer, hold immense promise.

About the Author

Natasha Loder is the health care correspondent for The Economist. She writes about biotechnology, medical science and the pharmaceutical industry. 

Comment on this summary or Начать обсуждение